RETROSPECTIVE - 'SPECIAL TREATMENT': Pfizer CEO Received $24.3 Million in Total Compensation for 2021

Source: CNBC

Published: MAR 18 2022

By: Spencer Kimball

• Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021, a 15% increase over the prior year.
• Bourla’s total equity holdings, nearly 597,000 shares, are worth more than $32 million as of Thursday’s closing price $54.24.
• He’s entitled to a golden parachute of nearly $113 million, which was valued at end of December 2021.

Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021, a 15% increase over the prior year as the company’s full-year profit more than doubled with the successful rollout of its Covid vaccine.

Bourla took home a cash incentive of $8 million on top of his salary of $1.69 million. He also received stock and options totaling $13.2 million as well as $1.38 million in other compensation.

RELATED: 

'CONSPIRACY THEORY' PARTIALLY CONFIRMED: Former Veterinarian and Pfizer CEO Announces Tracker Chips in Pills to Ensure 'Medical Compliance'

FEDERAL DOCUMENTS: U. Pittsburgh Harvesting Organs of Full-Term Aborted Babies as Old as 42 Weeks, Some with Possibly Beating Hearts

MORE CORRUPTION EXPOSED: Nonprofit Watchdog Uncovers $350 Million in Secret Payments to Fauci, Collins, And Other NIH Figures

Bourla’s total equity holdings, nearly 597,000 shares, are worth more than $32 million as of Thursday’s closing price of $54.24. He’s also entitled to a golden parachute valued at nearly $113 million as of Dec. 31, if the company is sold and he loses his job as a result.

Bourla also received more than $336,000 for home security and more than $60,000 for air travel. His total salary is 262 times higher than the median compensation for a normal employee at Pfizer.

Pfizer booked a profit of nearly $22 billion in 2021, double the previous year as the company’s Covid vaccine became the most widely administered shot against in the U.S. and the European Union. Sales from Pfizer’s Covid vaccine totaled $36.7 billion in 2021, making up about 45% of its annual revenue of $81.2 billion. Pfizer is projecting another $32 billion in vaccine sales this year.

Pfizer CEO Albert Bourla on need for fourth Covid vaccine dose, ‘panvaccine’ and more

The shot was developed with BioNTech, its German partner, who created the technology underlying the vaccine. Pfizer and BioNTech splits profits from the vaccine equally.

Pfizer’s shot was the first Covid vaccine to receive emergency authorization from the Food and Drug Administration in December and also the first to receive full approval from the FDA. The eligibility age has been gradually lowered to everyone over 5 years old.

Pfizer’s Covid treatment pill, Paxlovid, is also expected to become a hit, with the company projecting at least $22 billion in sales.

Read more at: CNBC.com

Discerning the Mystery is a website dedicated to awakening and educating the people to their true potential of mental, spiritual, emotional, and physical growth. It can be difficult work, but if just one person benefits from these efforts, it is entirely worth it. 

If you enjoy what you read here, please give the post a like and share on social media. Also, if you enjoyed this article, please consider leaving a donation.

Feel free to send us an email and tell us what you think. If you have any suggestions or subjects you would like to see discussed, please let us know.

Thank you for your support.